Evolve Royalties Debuts on the CSE With a Canadian Copper-Focused Royalty Portfolio and Significant Capital to Pursue Growth
EVREvolve commence trading on the CSE today, December 17, 2025 under the ticker symbol “EVR”
Evolve commence trading on the CSE today, December 17, 2025 under the ticker symbol “EVR”
Evolve Royalties Ltd. Expected To Commence Trading December 17, 2025 on CSE (EVR) Evolve Royalties Ltd. Expected To Commence Trading December 17, 2025 on CSE (EVR)
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Northfield Capital Corporation (TSX-V: NFD.A) (the “Company” or “Northfield”) announces that, as disclosed by Evolve Royalties Ltd. (“Evolve Royalties”) in its press release dated December 15, 2025, Evolve Royalties (previously Voyageur Mineral Explorers Corp. (“Voyageur”)) has completed its previously-announced business combination (“Business Combination”) with Evolve Strategic Element Royalties Ltd. (“Evolve Strategic”) and has listed its shares on the Canadian Securities Exchange (“CSE”). Trading of Evolve Royalties shares on the CSE is expected to begin on or about December 17, 2025, under the symbol “EVR”.
(NYSE:EVR) NEW YORK & LONDON--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Alexander Virgo has joined Evercore ISI as a senior managing director, based in London, covering global multi-industry companies. Mike Paliotta, CEO of Evercore ISI, said, “In today’s increasingly interconnected global economy, cross-sector insights are more valuable than ever. Mr. Virgo’s expertise in covering multi-industry companies positions us to better support clients navigating the evolving global landscape.” E
NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Bennett Blau has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the medical technology sector. He will be based in San Francisco. Naveen Nataraj, co-head of U.S. Investment Banking, said, “We are excited to welcome Bennett to Evercore. His deep expertise in medtech will further broaden our healthcare franchise to best serve our clients holistically.” “Medical te
Charles Schwab shares gained 0.2% to settle at $88.40 during the previous day's trading session, while QXO shares fell 1%.